Tenaya Therapeutics Q2 EPS $(0.34) Beats $(0.39) Estimate
Portfolio Pulse from Benzinga Newsdesk
Tenaya Therapeutics (NASDAQ:TNYA) reported a Q2 EPS loss of $(0.34), beating the analyst estimate of $(0.39) by 12.82%. This represents a 24.44% improvement over the $(0.45) loss per share from the same period last year.
August 08, 2024 | 9:17 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Tenaya Therapeutics reported a Q2 EPS loss of $(0.34), which is better than the analyst estimate of $(0.39) and shows a significant improvement from the $(0.45) loss per share in the same period last year.
The better-than-expected EPS and significant year-over-year improvement are likely to positively impact TNYA's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100